These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27515884)
1. Successful treatment of c-kit-positive metastatic Adenoid Cystic Carcinoma (ACC) with a combination of curcumin plus imatinib: A case report. Demiray M; Sahinbas H; Atahan S; Demiray H; Selcuk D; Yildirim I; Atayoglu AT Complement Ther Med; 2016 Aug; 27():108-13. PubMed ID: 27515884 [TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. Hotte SJ; Winquist EW; Lamont E; MacKenzie M; Vokes E; Chen EX; Brown S; Pond GR; Murgo A; Siu LL J Clin Oncol; 2005 Jan; 23(3):585-90. PubMed ID: 15659505 [TBL] [Abstract][Full Text] [Related]
3. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma. Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361 [TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Alcedo JC; Fábrega JM; Arosemena JR; Urrutia A Head Neck; 2004 Sep; 26(9):829-31. PubMed ID: 15350030 [TBL] [Abstract][Full Text] [Related]
5. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Pfeffer MR; Talmi Y; Catane R; Symon Z; Yosepovitch A; Levitt M Oral Oncol; 2007 Jan; 43(1):33-6. PubMed ID: 16757202 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma. Ghosal N; Mais K; Shenjere P; Julyan P; Hastings D; Ward T; Ryder WD; Bruce I; Homer J; Slevin NJ Br J Oral Maxillofac Surg; 2011 Oct; 49(7):510-5. PubMed ID: 21071117 [TBL] [Abstract][Full Text] [Related]
8. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland. Freier K; Flechtenmacher C; Walch A; Devens F; Mühling J; Lichter P; Joos S; Hofele C Oral Oncol; 2005 Oct; 41(9):934-9. PubMed ID: 16054424 [TBL] [Abstract][Full Text] [Related]
9. Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate. Lin CH; Yen RF; Jeng YM; Tzen CY; Hsu C; Hong RL Head Neck; 2005 Dec; 27(12):1022-7. PubMed ID: 16265655 [TBL] [Abstract][Full Text] [Related]
10. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations. Aubry MC; Heinrich MC; Molina J; Lewis JE; Yang P; Cassivi SD; Corless CL Cancer; 2007 Dec; 110(11):2507-10. PubMed ID: 17932891 [TBL] [Abstract][Full Text] [Related]
11. Characterization and localization of c-kit and epidermal growth factor receptor in different patterns of adenoid cystic carcinoma. Jain A; Shetty DC; Rathore AS; Kumar K J Cancer Res Ther; 2016; 12(2):834-9. PubMed ID: 27461660 [TBL] [Abstract][Full Text] [Related]
12. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Sun ZJ; Chen G; Hu X; Zhang W; Liu Y; Zhu LX; Zhou Q; Zhao YF Apoptosis; 2010 Jul; 15(7):850-63. PubMed ID: 20386985 [TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands. Faivre S; Raymond E; Casiraghi O; Temam S; Berthaud P J Clin Oncol; 2005 Sep; 23(25):6271-3; author reply 6273-4. PubMed ID: 16135502 [No Abstract] [Full Text] [Related]
14. Rare breast metastasis from adenoid cystic carcinoma of the submandibular gland. Krucoff KB; Shammas RL; Stoecker M; Tolnitch LA BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30068574 [TBL] [Abstract][Full Text] [Related]
15. Effects of imatinib mesylate on adenoid cystic carcinomas. Ochel HJ; Gademann G; Röcken C; Wördehoff H Anticancer Res; 2005; 25(5):3659-64. PubMed ID: 16101197 [TBL] [Abstract][Full Text] [Related]
19. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Holst VA; Marshall CE; Moskaluk CA; Frierson HF Mod Pathol; 1999 Oct; 12(10):956-60. PubMed ID: 10530560 [TBL] [Abstract][Full Text] [Related]
20. c-kit expression in adenoid cystic carcinoma does not have an impact on local or distant tumor recurrence. Aslan DL; Oprea GM; Jagush SM; Gulbahce HE; Adams GL; Gaffney PM; Savik K; Pambuccian SE Head Neck; 2005 Dec; 27(12):1028-34. PubMed ID: 16240323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]